Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-024759

Chief Operating Officer gave up 16,628 shares (to pay taxes)

  • Chief Operating Officer acquired 31,246 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2026-03-05 Option exercise +31,246 142,394 D
BILINSKY IGOR Chief Operating Officer 2026-03-05 Shares withheld for taxes −16,628 $4.58 $76,156 125,766 D
Derivatives
BILINSKY IGOR Chief Operating Officer 2026-03-05 Option exercise · Restricted Stock Units −31,246 62,504 D
Loading xslF345X05/tm268187-1_4seq1.xml…